The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC).

06.08.2011 11:58

 

Eur Heart J. 2011 Aug 6. [Epub ahead of print]

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Collaborators (220)

Berry CDoughty RNGranger CKøber LMassie BMcAlister FMcMurray JPocock SPoppe KSwedberg KSomaratne JWhalley GAAhmed AAndersson BBayes-Genis ABerry CCowie MCubbon RDoughty RNEzekowitz JGonzalez-Juanatey JGorini M,Gotsman IGrigorian-Shamagian LGuazzi MKearney MKøber LKomajda Mdi Lenarda ALenzen MLucci DMacín SMadsen B,Maggioni AMartínez-Sellés MMcAlister FOliva FPoppe KRich MRichards MSenni MSquire ITaffet GTarantini LTribouilloy C,Troughton RTsutsui HWhalley GADoughty RNEarle NPerera KPoppe KWhalley GADobson JPocock SPoppe KDoughty RN,Whalley GAndersson BHall CRichards AMTroughton RLainchbury JBerry CHogg KNorrie JStevenson KBrett MMcMurray J,Pfeffer MASwedberg KGranger CBHeld PMcMurray JJMichelson ELOlofsson BOstergren JYusuf SKøber LTorp-Pedersen C,Ahmed ALenzen MJScholte Op Reimer WJBoersma EVantrimpont PJFollath FSwedberg KCleland JKomajda MGotsman I,Zwas DPlaner DAzaz-Livshits TAdmon DLotan CKeren AGrigorian-Shamagian LVarela-Roman AMazón-Ramos PRigeiro-Veloso PBandin-Dieguez MAGonzalez-Juanatey JRGuazzi MMyers JArena RMcAlister FAEzekowitz JArmstrong PWCujec B,Paterson ICowie MRWood DACoats AJThompson SGSuresh VPoole-Wilson PASutton GC, Martínez-Sellés MRobles JAPrieto LMuñoa MDFrades EDíaz-Castro OAlmendral JTarantini LFaggiano PSenni MLucci DBertoli DPorcu MOpasich CTavazzi L,Maggioni APKirk VBay MParner JKrogsgaard KHerzog TMBoesgaard SHassager CNielsen OWAldershvile JNielsen HKober LMacín SMPerna ERCimbaro Canella JPAlvarenga PPantich RRíos NFarias EFBadaracco JRMadsen BKHansen JF,Stokholm KHBrons JHusum DMortensen LSBayes-Genis AVazquez RPuig TFernandez-Palomeque CBardají APascual-Figal DOrdoñez-Llanos JValdes MGabarrus APavon RPastor LGonzalez-Juanatey JRAlmendral JFiol MNieto VMacaya CCinca J,Bayes de Luna ANewton JDBlackledge HMSquire IBWright SPWhalley GADoughty RNKerzner RGage BFFreedland KERich MWHuynh BCRovner AFreedland KECarney RMRich MWTaffet GETeasdale TABleyer AJKutka NJTribouilloy RJRusinaru D,Mahjoub HSoulière VLévy FPeltier MTsutsui HTsuchihashi MTakeshita AMaccarthy PAKearney MTCubbon RNolan JLee AJ,Prescott RJShah AMBrooksby WPFox KAVarela-Roman AGonzalez-Juanatey JRBasante PTrillo RGarcia-Seara JMartinez-Sande JLGude F.

Abstract

Aims A substantial proportion of patients with heart failure have preserved left ventricular ejection fraction (HF-PEF). Previous studies have reported mixed results whether survival is similar to those patients with heart failure and reduced EF (HF-REF). Methods and results We compared survival in patients with HF-PEF with that in patients with HF-REF in a meta-analysis using individual patient data. Preserved EF was defined as an EF ≥ 50%. The 31 studies included 41 972 patients: 10 347 with HF-PEF and 31 625 with HF-REF. Compared with patients with HF-REF, those with HF-PEF were older (mean age 71 vs. 66 years), were more often women (50 vs. 28%), and have a history of hypertension (51 vs. 41%). Ischaemic aetiology was less common (43 vs. 59%) in patients with HF-PEF. There were 121 [95% confidence interval (CI): 117, 126] deaths per 1000 patient-years in those with HF-PEF and 141 (95% CI: 138, 144) deaths per 1000 patient-years in those with HF-REF. Patients with HF-PEF had lower mortality than those with HF-REF (adjusted for age, gender, aetiology, and history of hypertension, diabetes, and atrial fibrillation); hazard ratio 0.68 (95% CI: 0.64, 0.71). The risk of death did not increase notably until EF fell below 40%. Conclusion Patients with HF-PEF have a lower risk of death than patients with HF-REF, and this difference is seen regardless of age, gender, and aetiology of HF. However, absolute mortality is still high in patients with HF-PEF highlighting the need for a treatment to improve prognosis.

PDF COMPLETO